| Date Filed | Type | Description |
| 10/12/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/14/2018 |
4
| ABG Management Ltd (10% Owner) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Sold 189,754 shares
@ $5.0597, valued at
$960.1k
Sold 29,137 shares
@ $5.0059, valued at
$145.9k
Sold 78,677 shares
@ $4.9159, valued at
$386.8k
|
|
| 02/08/2018 |
4
| ABG Management Ltd (10% Owner) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Sold 512,912 shares
@ $6.7541, valued at
$3.5M
Sold 150,000 shares
@ $7.1865, valued at
$1.1M
|
|
| 02/07/2018 |
4
| ABG Management Ltd (10% Owner) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Sold 16,265 shares
@ $8.0038, valued at
$130.2k
Sold 37,483 shares
@ $8.0038, valued at
$300k
Sold 16,973 shares
@ $8.0038, valued at
$135.8k
|
|
| 01/31/2018 |
4
| ABG Management Ltd (10% Owner) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Sold 17,214 shares
@ $7.6063, valued at
$130.9k
Sold 53,786 shares
@ $7.6527, valued at
$411.6k
Sold 39,667 shares
@ $7.6063, valued at
$301.7k
Sold 124,333 shares
@ $7.6527, valued at
$951.5k
Sold 17,963 shares
@ $7.6063, valued at
$136.6k
Sold 57,037 shares
@ $7.6527, valued at
$436.5k
|
|
| 08/17/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/17/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/27/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 04/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 01/27/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 01/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 10/24/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 10/20/2016 |
SC 13D
| Ally Bridge LB Healthcare Master Fund Ltd reports a 17.6% stake in Biocept, Inc. |